//
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry
Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch Block
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study